Search Results - "SENDLER, A"

Refine Results
  1. 1

    Metabolic response evaluation by PET during neoadjuvant treatment for adenocarcinoma of the esophagus and esophagogastric junction by Sendler, A

    Published in Recent results in cancer research (01-01-2010)
    “…Following several randomized trials, neoadjuvant therapy in adenocarcinoma of esophagus and the esophagogastric junction can be seen as an international…”
    Get more information
    Journal Article
  2. 2

    Early Barrett's carcinoma/high grade intraepithelial neoplasia (HG-IEN): pro endoscopic treatment--pro surgical treatment by Wehrmann, T, Müller, M, Arnold, R, Sendler, A

    Published in Zeitschrift fur Gastroenterologie (01-06-2009)
    “…Who may treat early Barrett's carcinoma of the oesophagus? The incidence of adenocarcinoma of the oesophagus developing within Barrett's mucosa has…”
    Get more information
    Journal Article
  3. 3
  4. 4

    Delays in diagnosis and therapy of gastric cancer and esophageal adenocarcinoma by Witzig, R, Schönberger, B, Fink, U, Busch, R, Gundel, H, Sendler, A, Peschel, C, Siewert, J R, Lordick, F

    Published in Endoscopy (01-11-2006)
    “…In the past, there were long delays in the diagnosis of patients with cancer of the stomach or esophagus. The objective of this study was to describe current…”
    Get more information
    Journal Article
  5. 5

    Multidisciplinary approach to esophageal and gastric cancer by Stein, H J, Sendler, A, Fink, U, Siewert, J R

    Published in The Surgical clinics of North America (01-04-2000)
    “…Despite marked advances in surgical therapy for patients with esophageal, esophagogastric, and gastric cancers, the overall prognosis of these patients has not…”
    Get more information
    Journal Article
  6. 6

    Esophageal cancer: patient evaluation and pre-treatment staging by Stein, H.J., Brücher, B.L.D.M., Sendler, A., Siewert, J.R.

    Published in Surgical oncology (01-11-2001)
    “…Improvements in the overall survival of patients with esophageal cancer can in the future only be achieved by tailored therapeutic strategies which are based…”
    Get full text
    Journal Article
  7. 7

    Potential and futility of sentinel node detection for gastric cancer by Siewert, J R, Sendler, A

    Published in Recent results in cancer research (2000)
    “…The technique and scientific background of sentinel node dissection has spread extremely rapidly over the surgical community. Following the addition of this…”
    Get more information
    Journal Article
  8. 8

    Neutrophils Express the High Affinity Receptor for IgG (FcγRI, CD64) After In Vivo Application of Recombinant Human Granulocyte Colony-Stimulating Factor by Repp, R., Valerius, Th, Sendler, A., Gramatzki, M., Iro, H., Kalden, J.R., Platzer, E.

    Published in Blood (15-08-1991)
    “…Fc receptors are important effector molecules of neutrophilic granulocytes (polymorphonuclear neutrophils [PMN]), connecting phagocytic cells and the specific…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Surgical resection for cancer of the cardia by Siewert, J.R., Stein, H.J., Sendler, A., Fink, U.

    Published in Seminars in surgical oncology (01-09-1999)
    “…From the pathogenic and therapeutic point of view, adenocarcinomas of the esophagogastric junction (AEG) should be classified into adenocarcinoma of the distal…”
    Get full text
    Journal Article
  11. 11

    Proliferation kinetics and prognosis in gastric cancer after resection by Sendler, A, Gilbertz, K.-P, Becker, I, Mueller, J, Berger, U, Fink, U, van Beuningen, D, Siewert, J.R

    Published in European journal of cancer (1990) (01-09-2001)
    “…The influence of proliferation and proliferation kinetics on prognosis in gastric cancer after complete resection are controversial. In a prospective study we…”
    Get full text
    Journal Article
  12. 12

    Gastric cancer and adenocarcinoma of the esophagogastric junction: principles of neoadjuvant therapy by Lordick, F, Ott, K, Sendler, A

    Published in Chirurg (01-11-2011)
    “…According to the current European and German S3 guidelines, neoadjuvant chemotherapy is now an integral part of the treatment of locally advanced gastric…”
    Get full text
    Journal Article
  13. 13

    Antibodies TC-12 ("unique") and TH-111 (CD96) characterize T-cell acute lymphoblastic leukemia and a subgroup of acute myeloid leukemia by Gramatzki, M, Ludwig, W D, Burger, R, Moos, P, Rohwer, P, Grünert, C, Sendler, A, Kalden, J R, Andreesen, R, Henschke, F, Moldenhauer, G

    Published in Experimental hematology (01-12-1998)
    “…To extend the panel of monoclonal antibodies useful for immunophenotyping of acute leukemias, two new reagents, TC-12 and TH-111, were developed. TC-12 was…”
    Get more information
    Journal Article
  14. 14

    Preoperative staging of gastric cancer as precondition for multimodal treatment by Sendler, A., Dittler, H. J., Feussner, H., Nekarda, H., Bollschweiler, E., Fink, U., Helmberger, H., Höfler, H., Siewert, J. R.

    Published in World journal of surgery (01-07-1995)
    “…Preoperative staging of gastric cancer plays a crucial role in every multimodal treatment protocol. At present, staging intends to be far more than evaluation…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Increased risk of ischemic bowel complications during treatment with bevacizumab after pelvic irradiation: report of three cases by Lordick, Florian, Geinitz, Hans, Theisen, Joerg, Sendler, Andreas, Sarbia, Mario

    “…To assess the rate of severe bowel complications during treatment with the anti-vascular endothelial growth factor monoclonal antibody bevacizumab. We…”
    Get more information
    Journal Article
  17. 17

    Ösophaguskarzinom by Sendler, A., Strumberg, D., Adamietz, I.A., Tannapfel, A.

    Published in Der Onkologe (01-08-2008)
    “…Zusammenfassung Vor der Therapie des Ösophaguskarzinoms muss zwischen Plattenepithel- und Adenokarzinom unterschieden werden, auch wenn die R0-Resektion als…”
    Get full text
    Journal Article
  18. 18

    Carcinoma of unknown primary site (CUP syndrome) by Sendler, A, Strumberg, D, Tannapfel, A

    Published in Chirurg (01-07-2008)
    “…Despite the growing array of sophisticated diagnostic tools for establishing a diagnosis of human neoplasia, 2-6% of all cancer patients still present…”
    Get full text
    Journal Article
  19. 19

    Staging gastrointestinal cancer as a precondition for multimodal treatment by Siewert, J. R., Sendler, A., Dittler, H. J., Fink, U., Höfler, H.

    Published in World journal of surgery (01-03-1995)
    “…Staging gastrointestinal cancer is useful only if it has an impact on treatment. When applying modern multimodal therapies (i.e., neoadjuvant, adjuvant, or…”
    Get full text
    Journal Article
  20. 20

    Bronchogenic cyst of the esophagus with high tumor marker levels – a case report and review of the literature by Ott, K., Sendler, A., Heidecke, C.-D., Becker, K., Stein, H. J., Siewert, J. R.

    Published in Diseases of the esophagus (01-04-1998)
    “…Summary Bronchogenic cysts of the esophagus are rare in comparison with the relatively common bronchogenic cyst of the lung. Only a few cases have been…”
    Get full text
    Journal Article